254 related articles for article (PubMed ID: 29622904)
41. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
Leite NC; Salles GF; Araujo AL; Villela-Nogueira CA; Cardoso CR
Liver Int; 2009 Jan; 29(1):113-9. PubMed ID: 18384521
[TBL] [Abstract][Full Text] [Related]
43. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
[TBL] [Abstract][Full Text] [Related]
44. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Ha Y; Hwang SG; Rim KS
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28749418
[TBL] [Abstract][Full Text] [Related]
45. Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation.
Cazzo E; de Felice Gallo F; Pareja JC; Chaim EA
Obes Surg; 2014 Apr; 24(4):666-8. PubMed ID: 24415281
[TBL] [Abstract][Full Text] [Related]
46. Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients.
Bulum T; Kolarić B; Duvnjak M; Duvnjak L
Ren Fail; 2014 Apr; 36(3):372-7. PubMed ID: 24455970
[TBL] [Abstract][Full Text] [Related]
47. Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study.
Goyal O; Nohria S; Goyal P; Kaur J; Sharma S; Sood A; Chhina RS
Sci Rep; 2020 Dec; 10(1):21117. PubMed ID: 33273703
[TBL] [Abstract][Full Text] [Related]
48. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
Hsieh CJ; Wang PW; Hu TH
PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
[TBL] [Abstract][Full Text] [Related]
49. Study on Alanine Aminotransferase in Patients of Type 2 Diabetes Mellitus.
Ahamed F; Karim MR; Haque MA; Rashid MH; Habib MA; Moniruzzaman M; Ekram MS
Mymensingh Med J; 2021 Apr; 30(2):343-350. PubMed ID: 33830112
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.
Li TT; Wang AP; Lu JX; Chen MY; Zhao CC; Tang ZH; Li LX; Jia WP
Diabetes Metab; 2018 Nov; 44(5):437-443. PubMed ID: 29631765
[TBL] [Abstract][Full Text] [Related]
51. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study.
Foschi FG; Bedogni G; Domenicali M; Giacomoni P; Dall'Aglio AC; Dazzani F; Lanzi A; Conti F; Savini S; Saini G; Bernardi M; Andreone P; Gastaldelli A; Casadei Gardini A; Tiribelli C; Bellentani S; Stefanini GF
BMC Gastroenterol; 2018 Nov; 18(1):177. PubMed ID: 30486798
[TBL] [Abstract][Full Text] [Related]
53. Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease.
Shin HK; Park JH; Yu JH; Jin YJ; Suh YJ; Lee JW; Kim W;
Sci Rep; 2021 Sep; 11(1):18004. PubMed ID: 34504179
[TBL] [Abstract][Full Text] [Related]
54. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
[TBL] [Abstract][Full Text] [Related]
55. Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.
Yan LH; Mu B; Guan Y; Liu X; Zhao N; Pan D; Wang SZ
J Diabetes Investig; 2016 Nov; 7(6):889-894. PubMed ID: 27181828
[TBL] [Abstract][Full Text] [Related]
56. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
[TBL] [Abstract][Full Text] [Related]
57. Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults.
Lee S; Ko BJ; Gong Y; Han K; Lee A; Han BD; Yoon YJ; Park S; Kim JH; Mantzoros CS
Eur J Nutr; 2016 Feb; 55(1):327-33. PubMed ID: 25648740
[TBL] [Abstract][Full Text] [Related]
58. Most overweight and obese Indian children have nonalcoholic fatty liver disease.
Pawar SV; Zanwar VG; Choksey AS; Mohite AR; Jain SS; Surude RG; Contractor QQ; Rathi PM; Verma RU; Varthakavi PK
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):853-861. PubMed ID: 27740518
[TBL] [Abstract][Full Text] [Related]
59. Correlation between income and non-alcoholic fatty liver disease in a Chinese population.
Hu W; Liu Z; Hao HR; Yu WN; Wang XQ; Shao XJ; Wu XJ; Wen SR; Fan YQ; Ni YJ
Ann Endocrinol (Paris); 2020 Dec; 81(6):561-566. PubMed ID: 32987003
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
Behairy MA; Sherief AF; Hussein HA
Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
